MINITERY OF EDUCATION MINISTRY OF

AND TRANING DEFENCE

MILITARY MEDICAL UNIVERSITY

NGO DAC SANG

RESEARCH ON COMPLICATIONS

AFTER HEPATECTOMY FOR CANCER

ACCORDING TO TON THAT TUNG’S METHOD

Speciality: Surgical gastreoterology

Code: 62 72 01 25

SUMMARY OF PHD THESIS IN MEDICINE

HA NOI – 2017

COMPLETED THESIS AT

MILITARY MEDICAL UNIVERSITY

Full name of supervisor:

1. Prof. Dr. Le Trung Hai

2. Dr. Do Manh Hung

Reviewer 1: Asso. Prof. Dr. Nguyen Tien Quyet

Reviewer 2: Prof. Dr. Pham Nhu Hiep

Reviewer 3: Asso. Prof. Dr. Nguyen Quang Nghia

The thesis will be presented before the Board of appraising

thesis at basic level Military Medical University

Time: hour, day month , 2018

The thesis could be found at:

1. National library.

2. Library of Military Medical University.

1

INTRODUCTION

There are a wide variety of treatment methods such as

hepatotectomy, liver transplant, percutaneous ethanol injection therapy,

radio-frequency ablation, transcatheter arterial chemoembolization and

chemotherapy. Among them, hepatic resection is the most basic and

absolute method to remove tumors from the body. In case of minor liver

resection less than 3 segments, there are fewer complications, however,

morbidity rate tends to be higher for major hepatic resection (over 3

segments). Some other studies indicated that the overall mortality post-

hepatectomy was found in 3.1% and ranged from 7.2 - 15% after major

hepatic resection. The overall morbidity rate accounted for over 30%

and increased up to 75% after major hepatic resection. There are a

number of risk factors which increase the rate of complication after

surgical treatment including: age, gender, ASA score, degree of liver

resection, residue liver volume, operation time; intraoperative blood

loss, intraoperative transfusion, cirrhosis, preoperative chemotherapy...

In the world, there have been many researches on the complications

after hepatectomy for cancer, however, the rate of the complication is

different among the authors. In recent years, some studies on

hepatectomy for cancer have been reported, nevertheless, these

researches only put emphasis on evaluation of liver resection, statistics

without giving details on risk predictors of complications. On a basis,

we conducted this study with a view to:

Identifying complications after hepatic resection according to

Ton That Tung’s procedure.

Evaluating risk factors for complications after hepatic resection

according to Ton That Tung’s procedure.

2

3. New contribution to the thesis

In the same study based on Ton That Tung’s approach, we

identified complication rate of 23.34%; of which, the pleural effusion

(11.99%); ascites (8.52%); liver failure (3.47%); post-operative

bleeding (1.26%); bile leakage (1.89%); kidney dysfuction (0.32%);

abscess (0.32%). There were four factors: males, albumin < 35 g/L;

resection of three or four liver segments and operation time ≥ 300

minutes. Nevertheless, that only two risk factors of liver resection of

three or four segments and operation time ≥ 300 minutes were

independent ones of pleural effusion after hepatectomy.

In univariable analysis, six factors including males, cirrhosis,

tumor size > 10 cm; pre-operative platelet < 100 G/L; resection of

three or four liver segments and operation time ≥ 300 minutes are

independent risk factors of complication after operation. Nevertheless,

that only four factors: cirrhosis; perative platelet < 100 G/L; resection

of three or four liver segments and operation time ≥ 300 minutes were

independent risk factors for complication after hepatectomy.

4. Thesis structure

The thesis has 116 pages, of which:

Introduction: 2 pages.

Chapter 1 : Overview: 34 pages.

Chapter 2: Objects and research methods: 18 pages.

Chapter 3: Result: 26 pages.

Chapter 4: Discussion: 33 pages.

Conclusion 2 pages and recommendation 1 page.

The thesis: 33 tables, 11 charts, 22 figures; 141 references

including: 18 ones in Vietnamese and 123 ones in English.

3

Chater 1. OVERVIEW

1.1. Sugical methods

Ton ThatTung’s method (vascular control of liver

parenchyma). This method has two steps including total clampling of

hepatic pedicle in order to arrest haemorrhage (Pringle maneuver’s

procedure) and open directly into vascular pedicle in anterior liver

ligation. This technique is simple, fast, effective and easy-to-use,

particularly in emergency surgery, in cases of minor hepatic

resection so as to avoid accidents due to changes in anatomy of liver

pedicle structure. Hepatectomy should be performed according to 3

steps: (1): Liver parenchyma transection; (2): Ligation of hilar

elements into the liver; (3): Ligation of the hepatic vein into the liver.

1.2. Researches on sugical treatment of hepatic resection and

hepatectomy in cancer

1.2.1. Worldwide studies

1.2.2. In Vietnam

1.3. Post-hepatectomy complications

1.3.1. Liver failure

* Clinical symptoms

Post-operative liver failure is manifested clinically with various

symptoms such as jaundice, ascites, coagulation disorder, liver coma.

* Treatment methods: The therapy includes albumin

transfusion, fibrinogen, blood transfusion...

1.3.2. Post- operative bleeding

1.3.3. Bile leakage

1.3.4. Ascites

1.3.5. Pulmonary Complications

4

1.3.6. Wound infection

1.3.7. Residual abscess

1.4. Risk factors for complication after hepatic resection

1.4.1. Preoperative factor

* Ages, Gender, Classification Child - Pugh score

* Portal hypertension, levels of cirrhosis

1.4.2. Risk factors for complications intra-and-post surgical

hepatectomy

* ASA score and anesthesia time, Clamping maneuver

* Remaining liver volume, operative time, blood loss and

transfusion after surgery.

Chapter 2. SUBJECTS AND RESEARCH METHODS

2.1. Subjects

All patients diagnosed with liver cancer was performed

hepatectomy according to Ton That Tung’s method from January 2010

to December 2015 at Viet Duc Hospital.

2.1.1. Inclusion criteria

Age ≥ 15 years old, all patients were diagnosed with liver

cancer by post-hepatectomy histopathology; Child class A vs. B);

undergoing liver resection according to Ton That Tung’s method.

2.1.2. Exclusion criteria

Eliminate patients who refuse to cooperate in treatment;

Exclude non-cancerous hepatic resection; liver resection was

combined with some major surgery in the gastrointestinal tract

(gastrectomy, gastro-enterostomie ...); Cases of combined diseases

such as: heart failure, hypertension, cerebrovascular stroke, chronic

pulmonary cardiac, uncontrolled or life-threatening diabetes ...

5

2.2. Research methods

2.2.1. Research design

Descriptive cross- sectional studies, propective and

retrospective analysis.

2.2.2. Research steps

a. Retrospective research

- Study data collection including:

+ Clinical symptoms: Functional, symptoms of the existence.

+ Preoperative diagnostic imaging: Ultrasound, computed

tomography, magnetic resonance imaging.

+ Pre- operative examination: Blood group, blood cell count.

Liver function; prothrombin, total bilirubin, renal function,

creatinine. Hepatitis B and C markers (Anti - HBV, Anti - HCV).

Test of αFB, CA19 - 9.

+ Liver resection was performed according to Ton That Tung’s

technique. Diagnosis of liver cancer with posthepatectomy

histopathology. Postoperative examination: bilirubin, PT on days 1, 3, 5

postoperatively. Determine the postoperative complications through

treatment, management of complications, treatment results. Postoperative

ultrasound: abdominal, pleural effusion, abdominal ascites.

b. Perspective research

- Clinical examination, diagnosis and treatment tests including:

+ Basic tests: blood count, blood type, liver function, kidney

function, blood clotting, hepatitis B, C, ultrasound, computed

tomography, magnetic resonance imaging.

- Treatment for the patients, evaluation of the results.

6

2.2.3. Research index

Research index were recorded in both groups: retrospective and

prospective group. 2.2.3.1 Criteria for diagnosis of hepatocellular carcinoma

Identification of liver cancer by histopathology through surgical

specimens. Clinical, subclinical: (1) HBsAg (+); (2) tumor size over 2

cm; (3) rich in veins, showing signs of washout on computerized

tomography; (4) αFP  400 ng/mL.

2.2.3.2. Grouping by complications

Group one: have no complications; Group two: have complications.

2.2.3.3. General characteristics of the study group

a. Clinical characteristics

Age: divided into groups ≤ 30; 41 - 50; 51- 60 and > 60 years

old. Gender: risk factors for complications.

- Clinical symtoms: Abdominal pain; fever; jaundice, mucosal:

yes or no. Tiredness, weight loss, exhausion or not. Complications of

liver tumors: rupture tumors, major liver: yes or no. Transcatheter

arterial chemoembolization, portal vein embolization; numbers of

embolization. Other risk factors: alcoholism, beer.

b. Subclinical characteristics

* Peripheral blood cell tests:

 Evaluation based on Hb: moderate reduction: 70 to 100 g/L;

dramatic reduction: < 70 g/L.

 Plaletes: decreased platelets < 100 G/L.

* Biochemical tests:

 Glucose: increased > 7 mmol/L; decreased < 3,9 mmol/L.

 Albumin: decreased < 28 g/L; albumin deficiency < 35 g/L.

7

 Prothombin time (PT): liver failure PT < 50%.

 Total bilirubin level: normal < 1,5 mg/dL (25 μmol/L).

* Hepatic function assessment according to the Child - Pugh

Classsification: Child A: 5 - 6 total points. Child B: 7 - 9 total

points. Child C: 10 - 15 total points.

2.2.3.4. Surgical hepatectomy

a. Indications for hepatic resection

* Indications

+ Liver tumors are single or multiple tumors but localized in

the right or left liver, or in lobes, in segments or one or two

subsegments with a compensative liver function (Child A vs. B).

Tumor size: unlimited. Non-invasive blood vessels: portal vein,

inferor cava vena. There was no extrahepatic metastases. Major liver

resection: Child A; remnant liver volume body weight ratio ≥ 1%.

* Contraindications

+ Coagulation disorders was treated ineffectively. There was

cancer- metastases to other organs. Tumors have invaded the portal

vein or the inferior vena cava. It was positive for preoperative portal

vein thrombosis or abdominal veins.

b. Surgical hepatectomy

* Surgical technique

- Abdominal incision: Total clamping manuever (yes, no).

Hepatectomy according to Ton That Tung’s technique. Control liver

resection surface, bile leakage. Abdominal wiping, drainage. Wound

closure.

- Postoperative complications (liver failure, pleural efusion,

intraabdominal abscess, bleeding, biliary fistula, ascites), deaths.

8

* Post-operative follow-up

For patients who underwent major liver resection were done total

bilirubin level test, prothrombin time on days 1, 3, 5, 7 postoperatively.

- Abdominal ultrasound after surgical hepatectomy. Chest X-

ray test. Hospital stays, median hospital stays.

* Assessment results: Good: patients stable; deaths.

2.2.3.5. Criteria for defining the complications

a. Liver failure: Defining by bilirubin > 50µmol/L, PT < 50%) on

postoperative day 5.

b. Post- operative bleeding

c. Pleural effusion: X- ray films; ultrasound: pleural effusion.

d. Bile leakage: Bile leakage was defined as the drainage of 50 ml.

e. Ascites: Ultrasound or clinical examination showing daily ascites

fluid drainage exceeding > 500 mL.

g. Intraabdominal abscess:

2.2.3.6. Risk factors for complication

a. Pre-operative factors: Ages (≤ 60 vs. > 60 year old); sex (male vs.

female); liver function (Child A vs. Child B); tumor size (≥ 10 vs. <

10 cm); ASA score (< 3 vs. ≥ 3); pre-platelet count (< 100 G/L vs. ≥

100 G/L); PT time (< 70 vs. ≥ 70%).

b. Intraoperative factors: Operative time, min (< 300 vs. ≥ 300);

Pringle maneuver, min (≤ 10 vs. > 10); liver resection, segments (< 3

vs. ≥ 3 segments); cirrhosis: (yes vs. no); intraoperative transfusion.

2.2.4. Data collection

Statistical analyses were performed with software package

SPSS 15.0. A P value < 0.05 was defined as statistical significance.

9

Chapter 3. RESULT

3.1. Clinical and subclinical characteristics

3.1.1. Clinical characteristics

Table 3.3. Symptoms of the existence

Symptoms of the existence patiens percent

Jaundice 15 4.73

Large liver 10 3.15

Ruptured tumors 17 5.36

3.1.2. Subclinical characteristics

Table 3.4. Peripheral blood cell counts, prothrombin preoperative

Parameters Mean ± SD Range

Hemoglobin (g/L) 139.21 ± 18.64 51 - 186

Platelets (G/L) 220.80 ± 81.09 78 - 637

Prothrombin 92.82 ± 16.09 43.10 - 146.00

Table 3.5. Preoperative blood chemistry index

Parameters Mean ± SD Range

Glucose (mmol/L) 5.65 ± 1.48 2.6 - 15.6

GOT (U/L) 54.87 ± 55.82 15 - 662

GPT (U/L) 51.91 ± 51.04 6 - 413

Total bilirubin (µmol/L) 13.92 ± 7.88 1.4 - 78.4

Albumin (g/L) 40.72 ± 5.00 15 - 51

10

3.2. Surgical indications

3.2.1. Liver function

Table 3.9. Hepatic function assessment according to the Child-

Pugh Class

Child – Pugh No patiens Percent (%)

290 A 91.48

27 B 8.52

317 Total 100.00

3.2.2. Measurement of preoperative remnant liver volume

Average remnant liver volume was 598.75 ± 135.27 cm3 (the smallest was 414,67cm3; the largest was 916,15cm3). Remnant liver volume body weight ratio was 1.13 ± 0.14%.

3.3. Surgical techniques

Table 3.11. Liver resection types

Liver resection types No patiens percent

Right hemihepatectomy 22 6.94

Right extended hemihepatectomy 1 0.32

Left hemihepatectomy 39 12.30

Left extended hemihepatectomy 7 2.21

Central bisectionectomy (segments 4, 5, 8) 2 0.63

Resection of 3 segments (5, 6, 7 or 6, 7, 8) 6 1.89

Left lateral hepatectomy 59 18.61

Right posterior sectionectomy 44 13.88

Right anterior sectionectomy 4 1.26

Segmentectomy 133 41.96

Total 317 100.00

11

3.4. Postoperative outcome

3.4.1. Postoperative complications

Table 3.13. Complications

Complications No patiens percent

Overall complication 74 23.34

Liver failure 11 3.47

Post- operative hemorrhage 4 1.26

Pleural effusion 38 11.99

Ascites 27 8.52

Bile leakage 6 1.89

Kidney dysfuction 1 0.32

Abscess 1 0.32

Table 3.14. Pre- operative risk factors for pleural effusion

No Yes Parameters OR CI p (317 patiens) patients (%) patients (%)

≤ 60 217(87.86) 30(12.14) 0.47 - Ages 1.07 p > 0.05 2.46 > 60 62(88.57) 8(11.43)

Male 219(86.22) 35(13.78) 0.95 – Sex 3.20 p < 0.05 10.75 Female 60(95.24) 3(4.76)

< 35 24(75.00) 8(25.00) 1.17 - Albumin 2.83 p < 0.05 6.87 ≥ 35 255(89.47) 30(11.53)

< 100 9(90.00) 1(10.00) 0.10 - p > 0.05 0.81 Platelets 6.58 ≥ 100 270(87.95) 37(12.05)

no 227(87.64) 32(12.36) 0.33 - p > 0.05 0.82 Cirrhosis 2.56 yes 52(89.66) 6(10.34)

12

Table 3.15. Intra- postoperative risk factors for pleural effusion

No Yes Parameters OR CI p (317 patiens) patients(%) patients(%)

< 3 221(92.08) 19(7.92) Extent of 1.90 - 3.81 p < 0.05 resections 7.66 ≥ 3 58(7532) 19(24.68)

< 300 272(89.18) 33(10.82) Operatime 0.05 - 017 p < 0.05 (min) 0.57 ≥ 300 7(58.33) 5(41.67)

Table 3.16. Pre- operative risk factors for ascites

No Yes Parameters OR CI p (317 patiens) patients (%) patients (%)

≤ 10 256(91.43) 24(8.57) Size 0.30 - 1.06 p > 0.05 tumor 3.72 > 10 34(9189) 3(8.11)

< 35 27(84.38) 5(15.62) 0.16 - Albumin 0.45 p > 0.05 1.29 ≥ 35 263(92.28) 22(7.72)

< 100 5(50.00) 5(50.00) 3.48 - Platelets 12.96 p < 0.05 48.17 ≥ 100 285(92.83) 22(7.17)

no 57(98.28) 1(1.72) 0.85 - Cirrhosis 6.36 p < 0.05 47.86 yes 233(89.96) 26(10.04)

Table 3.17. Intraoperative and postoperative risk factors for ascites

No Yes Parameters OR CI p (317 patiens) patients (%) patients (%)

< 3 221(92.08) 19(7.92) Extent of 0.57 - 1.35 p > 0.05 resections 3.22 ≥ 3 69(89.61) 8(10.39)

< 300 280(91.80) 25(8.20) Operative 0.09 - 0.45 p > 0.05 time 2.15 ≥ 300 10(83.33) 2(16.67)

13

3.4.2. Postoperative outcome

Table 3.18. Postoperative blood chemistry test

Parameters Day 1 Day 3 Day 5

Creatinin 75.17 ± 23.18 73.18 ± 41.80 74.44 ± 73.26

Total Bilirubin 26.46 ± 22.91 33.65 ± 33.56 36.00 ± 48.77

%PT 69.08 ± 19.62 59.36 ± 19.67 65.01 ± 22.80

11 patients had total serum bilirubin level > 50 µmol/L and

prothrombin time index < 50% posthepatectomy on day 5.

3.5. Risk factors for complications after hepatectomy for cancer

3.5.1. Pre-operative risk factors

Table 3.19. Ages, sex with complication

Group 1 Group 2 Parameters OR CI p patients % patients %

≤ 60 186 75.30 61 24.70 Age 0.74 - p > 1.44 (years) 2.81 0.05 > 60 57 81.43 13 18.57

male 188 74.02 66 25.98 1.09 - p < Sex 2.41 5.33 0.05 female 55 87.30 8 12.70

Table 3.22. Pre-operative plaletes, prothrombin with complication

Group 1 Group 2 Parameters OR CI p patients % patients %

< 100 4 40.00 6 60.00 1.45 - 5.27 p < 0.05 Plaletes 19.22 ≥ 100 239 77.85 68 22.15

< 70 15 71.43 6 28.57 0.50 - 1.33 p > 0.05 %PT 3.56 ≥ 70 226 76.87 68 23.13

14

Table 3.23. Liever cirrhosis with complication

Group 1 Group 2 cirrhosis OR CI p patients % patients %

No 51 87.93 7 12.07 0.17 - 0.39 p < 0.05 0.91 Yes 192 74.13 67 25.87

Total 243 76.66 74 23.34

Table 3.25. Tumor size with complication

Group 1 Group 2 Tumor OR CI p size (cm) patients % patients %

≤ 10 221 78.92 21.08 59 0.19 - 0.39 p < 0.05 0.80 > 10 22 59.46 40.54 15

Total 243 76.66 23.34 74

3.5.2. Intraoperative risk factors

Table 3.28. Extent of hepatic resection with complication

Group 1 Group 2 Extent of OR CI p resections patients % patients %

< 3 segments 198 82.50 17.50 42 0.17 - 0.30 p < 0.05 0.52 ≥ 3 segments 45 58.44 41.56 32

Total 243 76.66 23.34 74

Table 3.29. Operative time and its complication

Group 1 Group 2 Operative OR CI p time patients % patients %

< 300 238 78.03 67 21.97 0.06 - 0.20 p < 0.05 0.65 5 41.67 7 58.33 ≥ 300

243 76.66 74 23.34 Total

15

3.5.3. Several independent risk factors for postoperative

complications of liver cancer

Table 3.31. Several independent risk factors of pleural effusion

Univariate analysis Multivariate analysis Factors OR (95% CI), p OR (95% CI), p

Gender 3.20 (0.95 - 10.75), p < 0.05 3.52 (0.99 - 12.51), p > 0.05

Albumin < 35 2.83 (1.17 - 6.87), p < 0.05 2.50 (0.98 - 6.39), p > 0.05

Resection of 3.81 (1.90 - 7.66), p < 0.05 0.28 (0.13 - 0.58), p < 0.05 3, 4 segments

Operative time 0.17 (0.05 - 0.57), p < 0.05 0.20 (0.06 - 0.69), p < 0.05 (≥ 300 min)

Multivariable analysis indicated that only two risk factors of

liver resection of three or four segments and operation time ≥ 300

minutes were independent ones of pleural effusion.

Table 3.32. Several independent risk factors for complications

Univariate analysis Multivariate analysis Factors OR(95% CI), p OR(95% CI), p

Gender 2.41(109 - 5.33), p < 0.05 2.26(0.97 - 5.27), p > 0.05

Liver cirrhosis 0.39(0.17 - 0.91), p < 0.05 0.42(0.17 - 1.02), p < 0.05

Tumor size > 10 0.39(0.19 - 0.80), p < 0.05 0.48(0.22 - 1.05), p > 0.05

Plaletes counts 5.27(1.45 - 19.22), p < 0.05 4.90(1.27 - 18.90), p < 0.05

Resection of 3, 4 0.30(0.17 - 0.52), p < 0.05 0.37(0.20 - 0.69), p < 0.05 segments

Operative time 0.20(0.06 - 0.65), p < 0.05 0.24(0.07 - 0.88), p < 0.05 (≥ 300 min)

16

Multivariable analysis indicated that only four risk factors:

cirrhosis; operative platelets count < 100 G/L; resection of three or

four liver segments and operation time ≥ 300 minutes were

independent fisk factors for complication after posthepatectomy .

Chapter 4: DISCUSSION

4.1. Complications after hepatectomy for cancer

4.1.1. Liver failure and liver failure prevention

The table 3.13 showed the incidence of postoperative liver

failure is 3.47%. In our study, the patients with posthepatectomy

liver failure have a full signs of clinical including: jaundice, multiple

ascites, coagulopathy disorders and hepatic encephalopathy...

In this study, 77 patients who were performed three or four

segments; 19 patients were estimated to have their hepatic segments resected. Median liver remnant was 598.75 ± 135.27 cm3. Remnant liver volume body weight ratio was 1.13 ± 0.14%.

According to Nguyen Quang Nghia, in order to be safe for

major liver resection, remnant liver volume body weight ratio should

be ≥ 1%. Van Tan et al said that to reduce liver failure after surgical

hepatic resection and the liver function well or relatively well,

parenchyma volume must be preserved at least over 30.

From Fazakas et al’s point of view, so as to be safe for major

liver resection, the remanant liver volume should be at least 30% or

remnant liver volume body weight ratio was ≥ 1%. Similarly, Ferrero

et al indicated that if the remaining liver volume ranged from 25 to

30%, the incidence of postoperative liver dysfunction was 23.1%.

Shirabe et al conducted a study on 80 patients undergoing major hepatectomy and he found that the remnant liver volume > 250 mL/m2

17

will ensure safety for major hepatectomy. Mullin et al also suggests

that remaining liver volume is > 25%, even > 40%, these patients still

develop liver failure. Therefore, the authors show that the remaining

liver volume was not closely correlated with posthepatectomy liver

function. Yigitler et al demonstrated that the mechanism leading to

liver failure after surgical hepatectomy is very complex.

4.1.2. Pleural effusion

Table 3.13, the pleural effusion rate is 11.99%, the main

treatment method is conservative, eight patients had required

paracentesis treament; three patients were performed the drainage in

continuous aspiration of the pleural cavity. Table 3.13 show that four

risk factors for pleural effusion are: male, total albumin level < 35 g/L,

liver resection of 3 or 4 segments and operative time > 300 minutes.

Van Tan et al in a restrospective study of 151 patients of liver

resection found that the rate of pleural effusion was 1.32%. Nguyen

Quang Nghia, the rate of pleural effusion was 18.6%.

Yang et al found that the incidence of pleural effusion was

18.4%, which is common complication. Another study by Jarnagin et

al found that pleural effusion was the most frequent complication and

explained 44.77% of complication in lung. Poon et al conducted a

study of 1,222 patients divided into two groups. The results showed

that the pleural effusion rate needed to be punctured in the first group

of 402 patients, which was 4.0% higher than the second group of 820

patients (2.8%) significant statistically (p < 0.05).

4.1.3. Post- operative bleeding

As indicated from table 3.13, postoperative hemorrhage is 1.26%,

including stitches 1 patient; 3 patients were repeated. Comparing with

18

the results of the surgery, two patients with bleeding owing to bleeding

technique; 1 patient bleeding from the liver-side. All 3 patients were

repeated before 12 hours from the time of detection for bleeding.

The time of surgery again to stop bleeding in the first 12 hours

is the best, aimed at avoiding massive postoperative hemorrhage due

to late surgery which may miss the gold chance, coagulation

disorders easily leads to liver failure. From Van Tan et al’s point of

view, the rate of posthepatectomy bleeding requiring surgery was

1.98%; 2 patients died due to delayed surgery, shock of blood loss

with coagulopathy disorders. In the study by Poon et al, he found that

careful selection of the patient, the indication of appropriate hepatic

resection can reduce the rate of postoperative bleeding. Another

analysis by Jarnagin et al (2002) showed a 1% reduction in

postoperative hemorrhage, but research did not show that the rate of

reoperative bleeding and reoperation.

4.1.4. Bile leakage

In our study, the table 3.13 reveals that the posthepatectomy

bile leakage rate was 1.89%. Compared with domestic and foreign

authors, this rate is quite low. A retrospective analysis by Van Tan et

al (2014) on 151 hepatectomy cases shows that the incidence of bile

leakage was 1.32%. In order to check whether postoperative bile

leakage occur, the residual liver can be covered with wet gauze to

avoid postoperative bile leakage, biological glue can applied to the

surface of the residual liver, operative time ≥ 300 minutes was an

independent risk factor for bile leakage after hepatectomy. Yu et al

found that the rate of postoperative bile leakage was about 4.8 -

7.6%. According to Dell et al, the major liver resection over of 3

19

segments, operative time ≥ 180 minutes were independently risk

factors for posthepatectomy bile leakage. 4.1.5. Ascites

From table 3.13 and table 3.16; 3.17, we found that the incidence

of ascites was 8.52%; univariate analysis showed that preoperative

platelet count less than 100 G/L and cirrhotic were risk factors for

post-operative ascites after surgical liver resection for cancer.

Underlying mechanisms of a massive amount of ascites after liver

resection is not well-understood. Previous studies revealed that in

patients with cirrhosis, portal hypertension can trigger massive ascites

by stimulating neurohormonal systems to promote renal water and

sodium resorption. Multivariate analysis revealed that blood loss greater

than 1000 mL, preoperative platelet count less than 100 G/L

independently increased the risk of ascites after posthepatectomy.

Additionally, liver resection for patients with liver cirrhosis and portal

hypertension existed before surgery might further damage liver function

and more elevation of portal pressure, thereby leading to the

development of postoperative ascites. Another cause of post-

hepatectomy ascites is lesions in intrahepatic lymphatics and high portal

pressure which may increase in excretion in ascites from the resected

area. Analysis by Chen et al on 651 cases found that five significant

factors: cirrhosis liver, high ICGR15 > 10%, portal hypotension, hypoalbuminemia ≤ 35 g/L and liver resection more 3 segments were

associated with the development of postoperative ascites.

20

4.2. Risk factors of complications after liver cancer resection

4.2.1. Pre-operative risk factors

4.2.1.1. Sex

Gender: table 3.19 show that male is a risk factor for

complication after liver cancer resection. Analyzis by Yang et al

showed that the gender was not a risk factor for posthepatectomy

complication. Another research by Reddy et al found that gender was

a risk factor for mortality and morbidity postoperatively, however,

the multivariate analysis found that gender was an independent risk

factor for mortality but gender was not risk factors for morbidity

after surgical liver cancer. Bachellier in a study of 55 cases showed

that male was an independent risk factor for postoperative liver

failure but no fatal surgical liver resection. Multivariate analysis by

Jarnagin showed that gender is a risk factor for morbidity

posthepatectomy but not a risk factor of mortality posthepatectomy.

4.2.1.2. Platelet count

Table 3.22, the low platelet count less than 100 G/L is a risk

factor for morbidity after hepatectomy for cancer; the patients with

preoperative low platelet count less than 100 G/L risk factor for

complication after surgery is 5.27 times higher than other patients.

Our research data is also consistent with some authors.

Analysis by Bruix et al found that preoperative platelet count was

associated with postoperative hepatic dysfunction. Taketomi et al

demonstrated that preoperative platelet count < 100 G/L and the

blood transfusion were independent predictors of postoperative

complications. In patients with lower platelet count < 100 G/L, risk

of morbidity was 4.65 times higher than other patients. Ishizawa et al

21

found that when preopertive platelet count <100 G/L were an

independent risk factor for postoperative ascites.

4.2.1.3. Liver cirrhosis

Univariate analysis from table 3.23 show that cirrhosis is a risk

factor for morbidity after surgical liver resection for cancer.

Analysis by Dokmak et al found that the mortality rate in

patients with F3 - F4 cirrhosis was higher 4.1 times than in other

patients. Research by Chan et al (2012), cirrhosis liver was one of

five independent risk factors for posthepatectomy ascites, of which

was higher 2.63 times than non-cirrhosis liver.

4.2.1.4. Tumor size

Table 3.25 show that the tumors larger than 10 cm in diameter

was a risk factor for postoperative liver resection complication.

Research by Le Loc showed that the main hepatic resection

was performed for tumors less than 10 cm in diameter; patients with

tumors larger than 10 cm in diameter and normal liver function, there

was still the possibility of liver resection. Report by Nguyen Quang

Nghia et al on 6 cases undergoing major hepatic resection (tumors

size diameter > 15 cm) showed that the reduction in the incidence of

morbidity and mortality after hepatectomy was quite difficult.

Analysis by Zhu et al on 739 patients showed that the larger

tumor size than 10 cm was a risk factor for complication after

surgical hepatic resection (p < 0.001). A restrospective analysis on

the results of liver resection by Chen et al found that larger tumor

size ≥ 10 cm was not a risk factor for complications.

22

4.2.2. Risk factors for intra-operative

4.2.2.1. Extent liver resection

Table 3.28 show that major liver resection of 3 or 4 segments

is a risk factor for complication after surgical hepatic resection for

cancer. Our study is also consistent with some authors worldwide.

According to Jarnagin et al, show that major hepatic resection

of more three segments were higher 1.2 times risk factor of overall

morbidity and higher 1.4 times postoperative mortality than other

patients. Another analysis by Poon et al showed that major liver

resection was considered to be independent risk factor for morbidity

posthepatectomy; the risk of morbidity by these patients was higher

1.57 times than other patients. Another study by Chan et al found

that major liver resection of more than three segments saw as one of

the five risk factors for ascites.

4.2.2.2. Operative time

Table 3.29 show that prolonger operative time ≥ 300 minutes was

a risk factor for morbidity (p < 0.05). Analysis by Yang et al showed

that operative time ≥ 180 minutes was not a risk factor for postoperative

morbidity. Study by authors found that the prolonged surgery was

identified at least 300 minutes; and the risk factors of posthepatectomy

morbidity was 2.78 times higher than other patients. As such, our study

is also consistent with the morbidity of the authors.

4.2.3. Several independent risk factors for complications after

hepatectomy for cancer

Multivariale analysis confirmed major hepatectomy of 3 or 4

segments and duration of operation of at least 300 minutes as

independent risk factors for pleural effusion.

23

Multivariable analysis confirmed: liver cirrhosis; preoperative

platelet count < 100 G/L; major hepatectomy of 3 or 4 segments and

prolonged surgery time ≥ 300 minutes as independent risk factors for

complication.

For patients with liver cancer accompanied with cirrhosis,

posthepatectomy poor prognosis decreased prothrombin time. Low

preoperative plalete count in cirrhosis liver has been demonstrated to

be due to blood clots in the spleen that cause hypersplenism; reduce

the supply of blood cells; at the same time inhibits marrow

production of blood cells. Therefore, preoperative low plalete count

is a poor prognosis for posthepatectomy. Some studies have

demonstrated low platelet count as an independent risk factor to

increase the rate of posthepatectomy complicaton. To keep safe in

major hepatic resection, remnant liver volumn should be > 26.5% for

normal liver function and 31% for poor liver function or the

remaining liver volume body weight ratio ≥ 1%. Small remaining

liver volume is at a high risk for postoperative liver failure. For large

tumors, deep in the abdominal cavity; major hepatectomy, dissection

technique is a challenging job, which results in damage the

diaphragm, circulatory system, lymphatic system surrounding the

liver .., therefore operative time is longer. Prolonged surgery time is

a risk factor for posthepatectomy complication.

CONCLUSION

1. Complications after hepatectomy for cancer

* The techniques of liver resection was applied in our study,

including: Right hemihepatectomy 6.94%; right extented

hemihepatectomy: 0.32%. Left hemihepatectomy 12.30%; left extended

24

hemihepatectomy: 2.21%. Central bisectionectomy (segments 4, 5, 8):

0.63%. Liver resection of three segments 5, 6, 7 or 6, 7, 8: 1.89%. Left

lateral hepatectomy: 18.61%. Right posterior sectionectomy: 13.88%.

Right anterior sectionectomy: 1.26%. Segmentectomy: 41.96%.

* Complications after hepatectomy for cancer according to Ton

That Tung’s approach: The complications rate was 23.34%; of which

pleural effusion 11.99%; ascites 8.52%; live failure 3.47%;

postoperative hemorrhage 1.26%; bile leakage 1.89%; kidney failure

0.32% and intraabdomal abscess 0.32%. 01 patients can have two or

three combined complications. One complication accounted for

19.87%; two or more than two complications were found in 3.47%.

2. Risk factors for complications after hepatectomy for

cancer according to Ton That Tung’s procedure

Univariable study, we investigated risk factors of

complications including 4 factors: males, albumin < 35 g/L; resection

of 3 or 4 liver segments and operation time ≥ 300 minutes.

Multivariable analysis indicated that only 2 factors of liver resection

of 3 or 4 segments and operation time ≥ 300 minutes were

independent risk factors of pleural effusion after posthepatectomy.

There are six factors including males, cirrhosis, tumor size >

10 cm; pre-operative platelet < 100 G/L; resection of 3 or 4 liver

segments and operation time ≥ 300 minutes are independent risk

factors of complication after operation. Nevertheless, a multivariable

analysis indicated that only four factors: cirrhosis; operative platelet

counts < 100 G/L; resection of 3 or 4 liver segments and operation

time ≥ 300 minutes were independent fisk factors for complication

after surgical hepatectomy.

LIST OF THE WRITER’S PUBLISHED RESEARCH

PROJECTS RELATED TO THE THESIS

1. Ngo Dac Sang, Le Trung Hai, Do Manh Hung (2017),

“Identifying Complications After Hepatectomy According To

Ton That Tung’s Approach”, Journal of Medicine and

Pharmacy, 42(9), pp. 78 - 83.

2. Ngo Dac Sang, Le Trung Hai, Do Manh Hung (2017),

“Assessment Of Risk Factors Of Complications After Cancer -

Induced Hepatectomy According To Ton That Tung’s

Approach”, Journal of 108 - Clinical Medicine and Pharmacy,

12(9), pp. 46 - 51.